Portfolio · X-ray
What your mutual funds really own
Add the funds you hold, and optionally how much you have in each. See the companies, sectors and company sizes your money ends up in when the funds are combined — including what you may own more of than you realise.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
Your funds
1 of 8 chosen
Portfolio summary
Your 1 fund combined, weighted by the amounts above.
9 stocks each make up more than 5% of your combined equity (GlaxoSmithKline Pharmaceuticals Limited, Zydus Lifesciences Limited, Strides Pharma Science Limited, Pfizer Limited and others). Healthcare is more than 25% of it. These are descriptions of the mix, not a view on it.
Biggest underlying exposures
Your largest stocks across all selected funds
- GlaxoSmithKline Pharmaceuticals LimitedHealthcare · in 1 of your fund14.40%
- Zydus Lifesciences LimitedHealthcare · in 1 of your fund13.94%
- Strides Pharma Science LimitedHealthcare · in 1 of your fund13.43%
- Pfizer LimitedHealthcare · in 1 of your fund10.95%
- Alivus Life Sciences LimitedNot classified · in 1 of your fund9.23%
- IPCA Laboratories LimitedHealthcare · in 1 of your fund8.88%
- Aurobindo Pharma LimitedHealthcare · in 1 of your fund7.56%
- Zydus Wellness LimitedFast Moving Consumer Goods · in 1 of your fund7.28%
- Colgate Palmolive (India) LimitedFast Moving Consumer Goods · in 1 of your fund5.13%
- Natco Pharma LimitedHealthcare · in 1 of your fund4.47%
- Dr. Reddy's Laboratories LimitedHealthcare · in 1 of your fund3.47%
- LG Electronics India LimitedConsumer Durables · in 1 of your fund0.88%
- Sumitomo Chemical India LimitedChemicals · in 1 of your fund0.39%
Sector exposure
Combined effective sector weights · NSE industry
Size mix: Large Cap 4.3% · Mid Cap 49.9% · Small Cap 45.7%.
Every company you own through these funds
13 companies · largest first
| Company | Sector | Size | Your exposure | In your funds |
|---|---|---|---|---|
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 14.40% | 1 |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 13.94% | 1 |
| Strides Pharma Science Limited | Healthcare | Small Cap | 13.43% | 1 |
| Pfizer Limited | Healthcare | Small Cap | 10.95% | 1 |
| Alivus Life Sciences Limited | Not classified | Small Cap | 9.23% | 1 |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 8.88% | 1 |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 7.56% | 1 |
| Zydus Wellness Limited | Fast Moving Consumer Goods | Small Cap | 7.28% | 1 |
| Colgate Palmolive (India) Limited | Fast Moving Consumer Goods | Mid Cap | 5.13% | 1 |
| Natco Pharma Limited | Healthcare | Small Cap | 4.47% | 1 |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 3.47% | 1 |
| LG Electronics India Limited | Consumer Durables | Large Cap | 0.88% | 1 |
| Sumitomo Chemical India Limited | Chemicals | Small Cap | 0.39% | 1 |
Each fund’s amount is treated as spread like its latest disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are left out, so for hybrid, debt or international funds only the Indian equity part is shown. Portfolios change every month. This is a description, not advice. Method →